Karl-johan J. Malmberg
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications
Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective.
Journal: Human gene therapy
Published: August 03, 2026
iPSC-derived NK cell therapy induces durable responses in glioblastoma and overcomes resistance via a B7-H3-targeted tri-specific killer engager.
Journal: Neuro-oncology
Published: October 07, 2025
Toggling of NKG2A expression drives functional specialization of iPSC-derived CAR NK cells.
Journal: bioRxiv : the preprint server for biology
Published: September 02, 2025
Rewiring natural killer cells for next-generation cancer therapies.
Journal: Cancer cell
Published: August 22, 2025
Expanded adaptive NKG2C+ NK cells exhibit potent ADCC and functional responses against HBV-infected hepatoma cell lines.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
The innate power of natural killer cells in cancer therapy.
Journal: Nature medicine
Published: May 12, 2025
The NKG2/HLA-E Axis Influence Outcomes of Haploidentical Transplantation.
Journal: Transplantation and cellular therapy
Published: March 01, 2025
Interleukin-12 decorated nanosized semiflexible Immunofilaments enable directed targeting and augmented IFNγ responses of natural killer cells.
Journal: Acta biomaterialia
Published: August 13, 2024
The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19.
Journal: Genes and immunity
Published: July 04, 2024
Egr2 to the rescue: nanoparticles revitalize natural killer cells in the fight against cancer.
Journal: The EMBO journal
Published: May 27, 2024
Last Updated: 09/26/2026